| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/2009 | US7549424 Method and apparatus for tissue treatment with laser and electromagnetic radiation |
| 06/23/2009 | CA2521509C Fast dissolving orally consumable films containing pharmaceutically active agents |
| 06/23/2009 | CA2459483C Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/23/2009 | CA2459400C Plaster for the treatment of dysfunctions and disorders of nails |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373611C Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 06/23/2009 | CA2370023C Transdermal therapeutic system with a highly effective neuroleptic agent |
| 06/23/2009 | CA2367387C Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/23/2009 | CA2355932C Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| 06/23/2009 | CA2336809C Water miscible macrolide solutions |
| 06/23/2009 | CA2304820C Stabilized bioactive preparations and methods of use |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/18/2009 | WO2009076673A2 Ligand conjugated thermotherapy susceptors and methods for preparing same |
| 06/18/2009 | WO2009076441A1 Collagen-based matrices with stem cells |
| 06/18/2009 | WO2009076369A1 Chitosan-based matrices and uses thereof |
| 06/18/2009 | WO2009076361A1 Orally disintegrating tablets comprising diphenhydramine |
| 06/18/2009 | WO2009076353A1 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 06/18/2009 | WO2009076270A2 Microstructured antimicrobial film |
| 06/18/2009 | WO2009076243A2 Novel uses of chloramphenicol and analogues thereof |
| 06/18/2009 | WO2009076236A2 Micronized opioid compositions, formulations and dosage forms and methods of making same |
| 06/18/2009 | WO2009076165A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption |
| 06/18/2009 | WO2009076158A1 Compositions for inducing immune responses |
| 06/18/2009 | WO2009075782A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| 06/18/2009 | WO2009075677A1 O-desmethyl-venlafaxine for treating major depressive disorder |
| 06/18/2009 | WO2009075652A1 Hollow multi-layered microspheres for delivery of hydrophilic active compounds |
| 06/18/2009 | WO2009075582A2 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids |
| 06/18/2009 | WO2009075401A1 Manufacturing method of functional drug nanoparticles using milling and functional drug nanoparticle formulation manufactured thereby |
| 06/18/2009 | WO2009075400A1 Skin contact type sap patch of rare earth minerals |
| 06/18/2009 | WO2009075391A1 Drug-containing nanoparticles |
| 06/18/2009 | WO2009075383A1 Skin external preparation and method of producing the same |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075324A1 Loxoprofen-containing aqueous plaster |
| 06/18/2009 | WO2009075309A1 Preparation composition |
| 06/18/2009 | WO2009075258A1 Transdermally absorptive preparation |
| 06/18/2009 | WO2009075142A1 Bactericidal cleanser composition |
| 06/18/2009 | WO2009075094A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/18/2009 | WO2009074995A1 Taste masked chewable compositions of sildenafil citrate |
| 06/18/2009 | WO2009074895A1 Cosmetic wipe that provides a visual indication of its effectiveness |
| 06/18/2009 | WO2009074853A2 Ophthalmic composition comprising phenylephrine |
| 06/18/2009 | WO2009074823A1 Composition for the treatment of a detached retina and method of production thereof |
| 06/18/2009 | WO2009074811A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 06/18/2009 | WO2009074666A1 Organic compounds |
| 06/18/2009 | WO2009074662A2 Organic compounds |
| 06/18/2009 | WO2009074609A1 Salts of active ingredients with polymeric counter-ions |
| 06/18/2009 | WO2009074517A1 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media |
| 06/18/2009 | WO2009074286A2 Pharmaceutical formulation comprising ezetimibe |
| 06/18/2009 | WO2009074274A1 Functionalised solid polymer nanoparticles containing epothilones |
| 06/18/2009 | WO2009074239A1 Pharmaceutical foams |
| 06/18/2009 | WO2009074233A1 Surface-modified nanoparticles |
| 06/18/2009 | WO2009074018A1 Medical use of ginsenoside or their mixture and composition thereof |
| 06/18/2009 | WO2009074004A1 A method for preparation of a health care wine of cordyceps |
| 06/18/2009 | WO2009073947A1 ORGANIC SALTS OF β-ALANINE |
| 06/18/2009 | WO2009073946A1 Particles in a capsule |
| 06/18/2009 | WO2009073944A1 USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION |
| 06/18/2009 | WO2009073942A1 Tropane alkaloids and trigonelline combinations and methods for administering the same |
| 06/18/2009 | WO2009073941A2 Ternary liposomal composition containing a polynucleotide |
| 06/18/2009 | WO2009073940A2 Use of phthalimide derivatives in the treatment of diseases |
| 06/18/2009 | WO2009056550A3 Bupropion hydrobromide and therapeutic applications |
| 06/18/2009 | WO2009056288A3 Stabilized statins |
| 06/18/2009 | WO2009043844A3 Orodispersible tablets |
| 06/18/2009 | WO2009030964A4 Amphiphilic oxalamide organogelators designed for gelation of organic solvents, water and hydrocarbon commercial fuels |
| 06/18/2009 | WO2008152444A3 Foamable waterless compositions with modulating agents |
| 06/18/2009 | WO2008144355A3 Stable, self-microemulsifying fenofibrate compositions |
| 06/18/2009 | WO2008135601A3 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation |
| 06/18/2009 | WO2008089709A3 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 06/18/2009 | WO2008083370A3 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 06/18/2009 | WO2008063910A3 Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions |
| 06/18/2009 | WO2004002414A3 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 06/18/2009 | WO2003092665A3 Ocular drug delivery systems and use thereof |
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 06/18/2009 | WO2003062648A3 Improved determination of gas solubility, entrained gas content, and true liquid density in manufacturing processes |
| 06/18/2009 | WO2003062199A3 Pace-a microspheres for delivery of antigens |
| 06/18/2009 | US20090156982 Transdermal treatment device and method |
| 06/18/2009 | US20090156965 Diagnostic interlabial pad |
| 06/18/2009 | US20090156693 Ophthalmic compositions containing polysaccharide/borate gelling system |
| 06/18/2009 | US20090156692 Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
| 06/18/2009 | US20090156677 Gabapentin-containing Solid Compositions and Process for Preparing the Same |
| 06/18/2009 | US20090156663 Functional Foods Comprising Flavonoids and Tocotrienols and Methods Thereof |
| 06/18/2009 | US20090156568 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 06/18/2009 | US20090156566 Method of treating middle ear infections |
| 06/18/2009 | US20090156564 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 06/18/2009 | US20090156549 Mucosal treatment |
| 06/18/2009 | US20090156527 Antiviral oligonucleotides targeting viral families |
| 06/18/2009 | US20090156464 Pharmaceutical Compositions and Methods for Insulin Treatment |
| 06/18/2009 | US20090156463 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 06/18/2009 | US20090155375 Compositions comprising a lipid and copolymer of styrene and maleic acid |
| 06/18/2009 | US20090155374 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/18/2009 | US20090155373 Cosmetic compositions and method which impart a healthy appearance to skin |
| 06/18/2009 | US20090155372 Method of manufacturing modified release dosage forms |
| 06/18/2009 | US20090155371 Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same |
| 06/18/2009 | US20090155370 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 06/18/2009 | US20090155369 Pharmaceutical composition containing levodopa, entacapone and carbidopa |
| 06/18/2009 | US20090155368 Pharmaceutical compositions |
| 06/18/2009 | US20090155367 Occlusion of Fallopian Tubes |
| 06/18/2009 | US20090155366 Osteoinductive materials |
| 06/18/2009 | US20090155365 Method for remotely controlling a sol-gel transition of hydrogels and method for delivering a drug using the same |
| 06/18/2009 | US20090155364 Transdiscal administration of anti-TNFalpha antibodies and growth differentiation factors |